The primary aim of this study is to discover whether patients with CMT type 1 and 2 have neuromuscular junction transmission deficits. The secondary aim is to collect information of different clinical and electrophysiological test procedures to perform possible future clinical trials in CMT patients.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Repetitive Nerve Stimulation - difference between CMT patients and healthy controls
Timeframe: Baseline
Repetitive Nerve Stimulation - difference between CMT patients and healthy controls
Timeframe: Baseline
Single Fiber Electro Myography (sfEMG) - difference between CMT patients and healthy controls
Timeframe: Baseline
Single Fiber Electro Myography (sfEMG) - difference between CMT patients and healthy controls
Timeframe: Baseline